High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates.
- 30 July 2001
- Vol. 19 (31) , 4544-4548
- https://doi.org/10.1016/s0264-410x(01)00183-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Hepatitis B epidemiology in Asia, the Middle East and AfricaVaccine, 2000
- Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8–10-year-old childrenVaccine, 1999
- Status of hepatitis B immunization programmes in 1998Vaccine, 1998
- Weltweite Epidemiologie der Hepatitis BInternational Journal of Public Health, 1998
- Hepatitis B Vaccine: Current IssuesAnnals of Pharmacotherapy, 1997
- Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNAVaccine, 1997
- High rate of seroconversion following administration of a single supplementary dose of recombinant hepatitis B vaccine in Iranian healthy nonresponder neonatesMedical Microbiology and Immunology, 1997
- Comparison study of the immunogenicity and safety of 5- and 10- μg dosages of a recombinant hepatitis B vaccine in healthy infantsThe Pediatric Infectious Disease Journal, 1996
- Immunogenicity of two different dosages (10 and 5 μg) of recombinant DNA hepatitis B vaccine in healthy neonatesVaccine, 1994
- Immunogenicity and Safety of Low Doses of Recombinant Yeast‐Derived Hepatitis B VaccineActa Paediatrica, 1990